Shares Of This Biotech Surge Following Collaboration Announcement For Monkeypox Research
Traders were quick to buy up shares of %TCBioPharm (Holdings) plc (Nasdaq: $TCBP) following the announcement, with shares of this micro cap quickly reaching up to $3.8799/share (+70.92%) at the early session high. This move could be indicative of this stock finally finding support for the first time in quite some time.
TC BioPharm (Holdings) PLC is a clinical-stage biopharmaceutical company focused on developing novel immunotherapy products that are based on its proprietary allogeneic gamma delta T (abbreviated as GD-T) cell platform.
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.

Comments
No comment